JAK2 and leukemia: JAK2 mutations may influence the TME by altering the production of cytokines, growth factors, and immune modulators, which in turn promote leukemia cell survival and immune evasion.[16-18] Immune evasion is another critical aspect of JAK2-driven leukemia.